ANIMATION

HuLuc 63

Share this article with:

PDL BioPharma asked XVIVO to show how a novel humanized antibody, HuLuc 63, appears to induce anti-tumor effects by binding to a protein expressed only on the surface of myeloma cells. This initiates antibody-dependent cytotoxic activity which targets myeloma cells while leaving healthy cells intact.

Share It:
Contact XVIVO

Client


PDL BioPharma

I LOVED XVIVO’s reel. I thought their attention to detail was amazing – the way they took the time to add subtle movements to cell walls or the primary visual was exactly what i was looking for but assumed they were too expensive – to my delight they were well within budget + they were also the clients first choice.

Art Director, DH Art Direction & Design, XCOVERY